OTCQX:MRVFF - Post by User
Post by
PDMitchellon Jan 21, 2014 6:42am
339 Views
Post# 22114286
Mallinckrodt’s new drug should generate ‘tens of millions’
Mallinckrodt’s new drug should generate ‘tens of millions’ But
Xartemis is expected to generate “hundreds of millions in revenue,” Does this suggest a potential conflict of interest or simply a realization that Pennsaid is not as effective or convenient as we've thought?
"Although Trudeau said Pennsaid will be a valuable product for generating revenue, he said
it won’t make as big of a splash as other drugs in the pipeline such as Xartemis XR, a 12-hour extended-release painkiller that is a combination of oxycodone and acetaminophen. Xartemis is currently awaiting FDA approval.
Xartemis is expected to generate “hundreds of millions in revenue,” Trudeau said. Plus, the product addresses acute pain, an area that yields about 200 million prescriptions annually in the U.S, million of which fall in Xartemis’ target market, according to Mallinckrodt."